Table 1.
Demographics and clinical characteristics of the study cohort
| Patient characteristics | PJP (n = 20) |
PJC (n = 22) |
Control (n = 19) |
p-value |
|---|---|---|---|---|
| Age (years, mean ± SD) | 52.90 ± 17.33 | 55.32 ± 14.81 | 51.95 ± 11.11 | 0.749 |
| BMI (kg/m2, mean ± SD) | 21.09 ± 3.74 | 20.69 ± 3.09 | 20.64 ± 3.23 | 0.644 |
| Sex, n(%) | 0.865 | |||
| Male | 15(75.00) | 15(68.18) | 13(68.42) | |
| Female | 5(25.00) | 7(31.82) | 6(31.58) | |
| Primary disease, n(%) | 0.827 | |||
| COPD | 4(20.00) | 7(31.82) | 3(15.79) | |
| ILD | 9(45.00) | 10(45.45) | 10(52.63) | |
| Pneumoconiosis | 3(15.00) | 1(4.55) | 3(15.79) | |
| Others* | 4(20.00) | 4(18.18) | 3(15.79) | |
| Type of lung transplantation, n(%) | 0.433 | |||
| Single | 13(65.00) | 10(45.45) | 11(57.89) | |
| Bilateral | 7(35.00) | 12(54.55) | 8(42.11) | |
| Postoperative duration, Median (P25, P75), days | 463(316, 851) | 570(253, 731) | 566(317, 712) | 0.998 |
BMI, body mass index; COPD, chronic obstructive pulmonary disease; ILD, interstitial lung disease; SD, standard deviation
*Other primary disease including bronchiectasis, paraquat lung, pulmonary arterial hypertension, pulmonary alveolar proteinosis, Langerhans cell histiocytosis, lymphangioleiomyomatosis, and bronchiolitis obliterans syndrome